FGFR1 amplification in squamous cell carcinoma of the lung. - Wikidata - awgldk - TriplyDB

FGFR1 amplification in squamous cell carcinoma of the lung.

FGFR1 amplification in squamous cell carcinoma of the lung.

http://www.wikidata.org/entity/Q36406190

about

Treatment of advanced squamous cell carcinoma of the lung: a review Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications The minority report: targeting the rare oncogenes in NSCLC Genetic characteristics and research progress of targeted therapy in squamous cell carcinoma Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.Prognostic value of FGFR gene amplification in patients with different types of cancer: a systematic review and meta-analysis.FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review.Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung Cancer Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALK Promising targets and current clinical trials in metastatic squamous cell lung cancer DNA copy number gains in malignant pleural mesothelioma Acquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expression The Role of FGFR1 Gene Amplification as a Poor Prognostic Factor in Squamous Cell Lung Cancer: A Meta-Analysis of Published Data Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.Discovery of novel non-ATP competitive FGFR1 inhibitors and evaluation of their anti-tumor activity in non-small cell lung cancer in vitro and in vivo.Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy.Fibroblast growth factor receptor 1 amplification in non-small cell lung cancer by quantitative real-time PCR Molecularly targeted therapies in non-small-cell lung cancer annual update 2014 Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease.FGFR1 amplifications in squamous cell carcinomas of the lung: diagnostic and therapeutic implications.Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma.Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma Squamous Cell Lung Cancer Associated With Systemic Sclerosis.Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practice.The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis.Genetic alteration profiling of patients with resected squamous cell lung carcinomas.FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.Fibroblast Growth Factor Receptor 1 (FGFR1), Partly Related to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) and Microvessel Density, is an Independent Prognostic Factor for Non-Small Cell Lung Cancer Programmed cell death-ligand 1 (PD-L1) expression and fibroblast growth factor receptor 1 (FGFR1) amplification in stage III/IV lung squamous cell carcinoma (SQC).Update on the Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in New Era of Personalized Medicine.Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?New targets in non-small cell lung cancer.Targeted therapy for NSCLC with driver mutations.Prognostic and predictive biomarkers in lung cancer. A review.Republished: lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?

P2860

Q26775392-C9CFECD8-391A-4EC9-9478-AA7D4BC82C79 Q26801718-086D756D-3E80-4266-8051-957FCED676AC Q26851636-2728C6B1-70B8-4A05-8DD1-96E0E4D66715 Q26865529-63A53C82-03CF-42C8-A698-CE2E2F92618A Q26998790-830F55B0-E29F-424F-8F29-7DD417B1895F Q27853055-A19CAAC6-5D50-494E-B88E-34ECB068FC5F Q27853061-ED30A916-2A56-415A-A51D-D69EA49E9259 Q27853171-451A5567-0CD6-459A-ABDB-91D72A6568F0 Q27853178-CA356A3E-2568-4E9C-981B-73A778C7EBD3 Q28077032-1B0CE73D-19DC-4BD5-88FB-C758BBDEA1C4 Q28083446-720CCA8B-EED9-41A1-A2C0-7026BAA6840D Q28083663-BAE99891-E893-4A59-9792-7E8FA2079078 Q28395184-022DC590-209F-460F-B3AE-3DE32F5370BB Q30365571-BBC59873-3157-41A5-AAC8-1ACA05EE7A09 Q31038314-E10A4F90-B63D-4A20-8831-16F62E1685E9 Q33750128-C65BD9CE-7BA5-4EA7-A7AC-C978551DAD4F Q34101045-7CCF1333-13CD-4212-AC99-4E19FB6C812A Q34460043-18BC065B-830E-47EB-93F3-CDDBC13447C9 Q35000497-1FDA6DD7-C249-40C9-80E0-EA8D7B671215 Q35047444-6F91A9A2-E622-4C06-9DF9-9EF5C2384A03 Q35136424-C6C8E636-C825-48F7-91F3-B74B10284D6E Q35149263-782E19F0-37BA-4C4B-A898-8E3ECC9244F8 Q35206634-3EAC86DE-1DD2-4D6E-A911-5F5CEA208DAC Q35273802-C0287B0E-FEC3-49B6-A3B1-788703DEC1F6 Q35540678-FFECE5D0-739F-47CC-B9AB-279E538F048F Q35837391-D3740F0F-F32A-4261-889A-20A185A55442 Q36130646-199B3C27-1943-4E76-8D7E-CD2D374A2AE0 Q36262168-803E416F-E283-4AA8-90ED-263CDD0DB92D Q36301400-2916B4A6-0FEF-4A95-A193-E4CE3E6DD1D0 Q36450685-B9D24B5A-B464-4D83-90AE-D3C012B56F26 Q37392781-F63123AC-35A7-4A10-BD08-70A95159AABA Q37462489-9DCA0D86-1AD6-48E0-A885-ACCB6F1890C7 Q37603125-28861AC9-865E-4C6D-9A6D-43B42B0539F4 Q37677845-49BCEC27-2112-4BA4-A020-7E11F6BC9C3A Q37721218-0539EFC3-FDE5-454D-A82C-D280234C5790 Q38105532-BBEC76B9-B7EC-4D56-8083-1B37549F3843 Q38114835-90769DDE-70BF-4161-873A-72A40F28FE4A Q38127728-DA3524C8-4383-4563-A45E-7D73B86F5EDE Q38178187-B08428F1-19D5-471E-8E3B-A15EF8E54475 Q38197071-54EE6718-1820-4D0F-9A2E-035F5B649D8B

P2860

FGFR1 amplification in squamous cell carcinoma of the lung.

http://www.wikidata.org/entity/Q36406190

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

FGFR1 amplification in squamous cell carcinoma of the lung.

@ast

FGFR1 amplification in squamous cell carcinoma of the lung.

@en

type

label

FGFR1 amplification in squamous cell carcinoma of the lung.

@ast

FGFR1 amplification in squamous cell carcinoma of the lung.

@en

prefLabel

FGFR1 amplification in squamous cell carcinoma of the lung.

@ast

FGFR1 amplification in squamous cell carcinoma of the lung.

@en

P1433

Q36406190-A3155753-88E1-48CB-8DED-D97762AA8807

P1476

Q36406190-7E068153-FAEC-49B2-9A35-D4CDB242900E

P2093

Q36406190-15369898-1D74-4483-9E8F-B6BEA8639906

Q36406190-18A83F82-914C-4BCF-8856-BAEED4AEE86E

Q36406190-5838D912-9A91-4D7E-B188-EA917971848B

Q36406190-68DE170F-23F0-46B6-8212-82E2232233DE

Q36406190-723C45B5-67D8-4AA3-B2C8-72B74F7113CD

Q36406190-87275A00-B16C-4F6B-9A89-F21864B2AB70

Q36406190-C4EADDA6-A8A5-42A6-A79A-625CCA763981

P2860

Q36406190-061C89FF-7783-4B3C-8A13-C2EEDFB8C51E

Q36406190-07EAECCF-EE5E-4B8A-9C92-655E7F51385F

Q36406190-0A7833C3-1B42-4560-A3D3-1C9E9316C645

Q36406190-0ACC3FD2-7BCF-43D4-98A1-A9A399919AC4

Q36406190-0DFD3696-8F3B-4C10-A4CD-C2A89743F314

Q36406190-14522798-320C-4D75-8316-6104E43D77AD

Q36406190-2B429F87-1003-41DD-8097-596764246269

Q36406190-31D256DB-4C9C-4819-BB84-882FADF0F387

Q36406190-33BDA5B6-AE39-45D8-920A-C9B95ADC8536

Q36406190-46025A03-E5C1-4FCA-B7C2-AB2CE4A34754

P304

Q36406190-1A6C8DAB-3434-4DE9-A5B8-E408E0D3A79D

P31

Q36406190-A0412BCC-A2EE-4EE8-BF7E-AE2160CBD040

P356

Q36406190-73CA19E1-8346-4396-9BEF-33585C14C77C

P433

Q36406190-A55E7F11-2695-40F6-810B-FC274BF21893

P478

Q36406190-9F9AE6D2-E9E0-456F-BD92-E3F02D1F29E3

P50

Q36406190-7680321D-5728-4ED5-8BC2-05FCC7E7FE42

P577

Q36406190-BF3F6AC0-810A-4912-A15F-C7732A91382D

P698

Q36406190-2BBCED2C-9A52-4D57-B4FC-7B5815F71C81

P932

Q36406190-11A75C6E-6481-473B-8784-DE1852ED158F

P356

JTO.0B013E31826AED28

P1433

Journal of Thoracic Oncology

P1476

FGFR1 amplification in squamous cell carcinoma of the lung.

@en

P2093

A John Iafrate

http://www.w3.org/2001/XMLSchema#string

David C Christiani

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Engelman

http://www.w3.org/2001/XMLSchema#string

Laura Morrissey

http://www.w3.org/2001/XMLSchema#string

Lecia V Sequist

http://www.w3.org/2001/XMLSchema#string

Rebecca S Heist

http://www.w3.org/2001/XMLSchema#string

Swathi Tammireddy

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

P304

1775-1780

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/JTO.0B013E31826AED28

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Mari Mino-Kenudson

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23154548

http://www.w3.org/2001/XMLSchema#string

P932

3500511

http://www.w3.org/2001/XMLSchema#string